The purpose of this research study is to better understand the causes of fatty liver recurrence and the development of metabolic illnesses such as diabetes, high blood pressure, weight gain, and abnormal cholesterol levels in patients who have undergone liver transplantation.

Patients transplanted for NASH, or a type of nonalcoholic fatty liver disease known as nonalcoholic steatohepatitis, cirrhosis are rapidly increasing in number and it is now the #2 listing diagnosis for liver transplantation. These patients typically have metabolic syndrome and have increased cardiovascular risk. 
   
Participants who have received a liver transplant for cirrhosis entirely or in part related to fatty liver will complete questionnaires, blood collection, and optional genetic testing.
   
Participation in this study will last for up to 10 years and participants will be compensated for their time.